column
Select articles
Standardization for diagnosis and treatment of hepatocellular carcinoma (2022 edition)Bureau of Medical Administration, National Health Commission of the People's Republic of China
2022, 21(2): 143-168. DOI: 10.3760/cma.j.cn115610-20220124-00053
Abstract
Chinese expert consensus on organ protection of transplantation (2022 edition)
China Liver Transplant Registry, National Center for Healthcare Quality Management in Liver Transplant, National Quality Control Center for Donated Organ Procurement, National Clinical Research Center for Orthopedics, Sports Medicine&Rehabilitation, Committee on Transplant Organ Quality Control, Branch of Organ Transplant Doctor, Zheng Shusen
2022, 21(2): 169-184. DOI: 10.3760/cma.j.cn115610-20220214-00078
Abstract
Chinese expert consensus on standardization process of hepatobiliary diseases in day surgery (2022 edition)
Editorial Board of Chinese Journal of Digestive Surgery, Cai Xiujun, Zhang Zhongtao
2022, 21(2): 185-190. DOI: 10.3760/cma.j.cn115610-20211228-00687
Abstract
Chinese expert consensus on case management of bariatric and metabolic surgery (2022 edition)
Chinese Society for Metabolic and Bariatric Surgery, Chinese Obesity and Metabolic Surgery Collaborative, Wang Cunchuan, Gao Lilian, Yang Wah
2022, 21(2): 191-198. DOI: 10.3760/cma.j.cn115610-20211201-00607
Abstract
Immunotherapy for hepacellular carcinoma: where there is hope, there is brightness
Fan Jia, Gao Qiang
2022, 21(2): 199-204. DOI: 10.3760/cma.j.cn115610-20220215-00080
Abstract
Perioperative diagnosis and treatment strategies of liver transplantation for liver cancer in precision medicine era
Zhou Jian, He Yifeng, Huang Xiaowu, Yang Xinrong
2022, 21(2): 205-209. DOI: 10.3760/cma.j.cn115610-20220110-00025
Abstract
Research progress of vascular interventional therapy in the conversion therapy of hepato-cellular carcinoma
Chen Minshan, Pan Yangxun
2022, 21(2): 210-216. DOI: 10.3760/cma.j.cn115610-20220106-00015
Abstract
Conversion therapy strategies for hepatocellular carcinoma
Lyu Guoyue, Jiang Chao, Sun Xiaodong
2022, 21(2): 217-223. DOI: 10.3760/cma.j.cn115610-20220125-00058
Abstract
Conversion therapy strategies for hepatocellular carcinoma in the era of targeted therapy combined with immunotherapy
Zeng Yongyi, Lin Kongying, Tang Shichuan
2022, 21(2): 224-230. DOI: 10.3760/cma.j.cn115610-20211130-00606
Abstract
Reflection and practice of long-term management of hepatocellular carcinoma
Sun Yuling, Zhu Rongtao, Wang Weijie
2022, 21(2): 231-236. DOI: 10.3760/cma.j.cn115610-20211122-00582
Abstract
Prognosis and influencing factors of liver transplantation for hepatocellular carcinoma using steatotic donor liver: a multicenter study
Yang Mengfan, Wang Rui, Pan Binhua, Su Renyi, Dong Siyi, Xu Xiao, Zheng Shusen, Wei Xuyong
2022, 21(2): 237-248. DOI: 10.3760/cma.j.cn115610-20220209-00072
Abstract
Analysis of influencing factors for anastomotic biliary stricture after liver transplantation
Liu Daqun, Sun Xiaodong, Qiu Wei, Chen Yuguo, Huang Heyu, Lyu Guoyue
2022, 21(2): 249-255. DOI: 10.3760/cma.j.cn115610-20211129-00602
Abstract
Influence of effects of transarterial chemoembolization before liver transplantation on the prognosis of hepatocellular carcinoma
Zhu Xiongwei, Li Ziqiang, Tian Yan, You Bo, Yang Yang, Lu Bin, Wu Zehao, Zhang Qing, Shu Qingming
2022, 21(2): 256-264. DOI: 10.3760/cma.j.cn115610-20211126-00596
Abstract
Application value of peripheral blood circulating tumor cell classification in the prediction of preoperative microvascular invasion of hepatocellular carcinoma
Pan Yujin, Li Dongxiao, Yang Jiuhui, Wang Ning, Tao Lianyuan, Tian Guangjin, Xiao Erwei, Yu Haibo, Li Deyu
2022, 21(2): 265-272. DOI: 10.3760/cma.j.cn115610-20220102-00002
Abstract
Clinical efficacy of precise hepatectomy for the treatment of recurrent unilateral hepato-lithiasis and prognostic factors analysis
Pu Tian, Chen Jiangming, Guo Qi, Jiang Dong, Li Zihan, Liu Fubao, Geng Xiaoping
2022, 21(2): 273-280. DOI: 10.3760/cma.j.cn115610-20211122-00589
Abstract
Clinical efficacy of avatrombopag combined with recombinant human thrombopoietin versus avatrombopag in the treatment of severe thrombocytopenia associated with chronic liver disease
Wang Yongshuai, Zhang Sai, Li Lei, Wang Wei, Wang Wei, Zhang Shenyu, Song Huachuan, Yao Huanzhang, Song Ruipeng, Liu Lianxin, Wang Jizhou
2022, 21(2): 281-286. DOI: 10.3760/cma.j.cn115610-20211230-00693
Abstract
Clinical value of split domino donor auxiliary liver transplantation
Zhang Wenjie, Xu Qingxiang, Li Guoqiang, Yu Decai, Yue Yang, Zhu Xinhua, Liu Qiaoyu, Cui Heng, Sun Beicheng
2022, 21(2): 287-294. DOI: 10.3760/cma.j.cn115610-20211230-00694
Abstract
CT examination anatomical features and clinical significance of paraesophageal vein in portal hypertension
Tian Mingguo, Bo Yang, Ding Ronghua, Chen Dazhi, Yang Yong, Liu Mingqi, Wu Jinhua
2022, 21(2): 295-302. DOI: 10.3760/cma.j.cn115610-20220129-00063
Abstract
Clinical efficacy of Atezolizumab and Bevacizumab in the treatment of initially borderline resectable advanced liver cancer
Yao Bowen, Xiang Junxi, Zheng Xin, Sun Hao, Yang Wei, Zhang Yuelang, Ye Feng, Zhao Dongli, Yao Yingmin, Liu Qingguang, Guo Cheng
2022, 21(2): 303-306. DOI: 10.3760/cma.j.cn115610-20220120-00045
Abstract
The construction and application of registry and follow‑up database in hepatobiliary tumor patients
Zhang Hui, Jiao Chenyu, Zhu Yongqian, Li Changxian, Xia Yongxiang, Li Xiangcheng, Wang Xuehao, Zhao Yang, Liu Jin
2022, 21(2): 307-312. DOI: 10.3760/cma.j.cn115610-20220129-00062
Abstract